HK Stock MarketDetailed Quotes

02096 SIMCERE PHARMA

Watchlist
  • 5.700
  • +0.050+0.88%
Market Closed Jul 12 16:08 CST
14.50BMarket Cap18.39P/E (TTM)

SIMCERE PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SIMCERE PHARMA Earnings Date

Currency: CNY

Period

FY2023 Annual Report

Mar 20, 2024

Revenue(YoY)

6.61B

+4.49%
EPS(YoY)

0.27

-23.93%
Analyst Rating

Strong Buy

Jul 12, 2024

SIMCERE PHARMA Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 20, 20242023/H2448.449M / 468.000M--
DatePeriodRevenue/EstimateEarnings Call
Mar 20, 20242023/H2448.449M / 468.000M--

SIMCERE PHARMA Earnings Reports

  • SIMCERE PHARMA: (I) POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 14, 2024 AND (II) PAYMENT OF FINAL DIVIDEND

    Jun 14 06:50 ET

  • SIMCERE PHARMA: NOTICE OF ANNUAL GENERAL MEETING

    May 23 04:30 ET

  • SIMCERE PHARMA: 2023 ANNUAL REPORT

    Apr 24 07:25 ET

  • SIMCERE PHARMA: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023

    Mar 20 10:31 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 12, 2024

    Strong Buy

    • Strong Buy

      91.67%

    • Buy

      8.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    %Chg